Invacare Corporation (IVC) Analysts See $-0.42 EPS

October 13, 2017 - By Linda Rogers

 Invacare Corporation (IVC) Analysts See $ 0.42 EPS
Investors sentiment increased to 1.94 in Q2 2017. Its up 0.56, from 1.38 in 2017Q1. It increased, as 6 investors sold Invacare Corporation shares while 30 reduced holdings. 24 funds opened positions while 46 raised stakes. 37.86 million shares or 11.78% more from 33.87 million shares in 2017Q1 were reported.
South Dakota Investment Council stated it has 129,800 shares or 0.04% of all its holdings. 26,496 were reported by Capstone Asset. Alliancebernstein Limited Partnership owns 0% invested in Invacare Corporation (NYSE:IVC) for 39,741 shares. National Bank & Trust Of Ny Mellon Corp owns 407,722 shares for 0% of their portfolio. Pub Sector Pension Board holds 0% or 16,380 shares. Citigroup owns 18,540 shares. Hotchkis & Wiley Capital Ltd Liability Corporation, California-based fund reported 1.33 million shares. 21,800 are held by Cornerstone Mgmt Lc. Great West Life Assurance Com Can has 44,139 shares. Brandes Investment Partners Ltd Partnership invested in 1.53M shares or 0.32% of the stock. Morgan Stanley stated it has 0% in Invacare Corporation (NYSE:IVC). Bartlett & Ltd Liability Corp has invested 0% in Invacare Corporation (NYSE:IVC). Northern Tru has 432,109 shares for 0% of their portfolio. Northpointe Cap Lc holds 0.81% or 585,126 shares in its portfolio. 97 were reported by Meeder Asset.

Since May 16, 2017, it had 0 buys, and 1 insider sale for $40,918 activity.

Analysts expect Invacare Corporation (NYSE:IVC) to report $-0.42 EPS on October, 30.They anticipate $0.05 EPS change or 13.51 % from last quarter’s $-0.37 EPS. After having $-0.63 EPS previously, Invacare Corporation’s analysts see -33.33 % EPS growth. The stock increased 3.91% or $0.55 during the last trading session, reaching $14.6. About 527,317 shares traded. Invacare Corporation (NYSE:IVC) has risen 42.93% since October 13, 2016 and is uptrending. It has outperformed by 26.23% the S&P500.

Invacare Corporation (NYSE:IVC) Ratings Coverage

Among 2 analysts covering Invacare Corporation (NYSE:IVC), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Invacare Corporation had 3 analyst reports since April 5, 2017 according to SRatingsIntel. The firm has “Overweight” rating by Stephens given on Monday, May 1. The firm has “Buy” rating given on Tuesday, September 26 by KeyBanc Capital Markets. The rating was maintained by Stephens with “Equal Weight” on Wednesday, April 5.

Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The company has market cap of $469.88 million. The Company’s geographical divisions are Europe; North America, which includes North America/Home Medical Equipment and Institutional Products Group (IPG) divisions, and Asia/Pacific. It currently has negative earnings. The Firm makes and distributes three product categories: mobility and seating, lifestyle and respiratory therapy.

Another recent and important Invacare Corporation (NYSE:IVC) news was published by Nasdaq.com which published an article titled: “Invacare Corporation (IVC) Ex-Dividend Date Scheduled for October 04, 2017” on October 03, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

Twitter Auto Publish Powered By : XYZScripts.com